Current Opinion in Pharmacology

SJR Rank #2,361H-index: 157SJR: 1.521Best quartile: Q1APC: US$3,510
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Drug DiscoveryQ1
  • PharmacologyQ1

Areas: Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Diverse Scientific and Economic StudiesReceptor Mechanisms and SignalingHuman auditory perception and evaluationNeuroscience and Neuropharmacology ResearchEducational Robotics and EngineeringAsthma and respiratory diseasesNeuropeptides and Animal PhysiologyIon channel regulation and functionDiet and metabolism studiesGastrointestinal motility and disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

2022202503570105140

Detailed Information

ISSN

1471-4973, 1471-4892

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.84

References per Document

47.11

Coverage

2001-2026

Scope

Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.

Metrics from SCImago Journal Rank 2025. View on SCImago